-

SLQT 10-DAY DEADLINE ALERT: SelectQuote (SLQT) Faces Investor Lawsuit After DOJ Steps into Medicare Sales Probe – Hagens Berman

SLQT Investors with Losses Encouraged to Contact Hagens Berman

SAN FRANCISCO--(BUSINESS WIRE)--SelectQuote Inc. (NYSE: SLQT), a digital insurance platform known for selling Medicare Advantage plans, is facing heightened legal scrutiny after the U.S. Department of Justice (DOJ) intervened in a whistleblower lawsuit alleging deceptive sales practices. The federal action triggered a sharp 19% drop in SelectQuote’s share price on May 1, 2025, and has now led to a securities class-action lawsuit filed on behalf of investors.

The suit, Pahlkotter v. SelectQuote Inc. et al., covers investors who purchased SelectQuote stock between September 9, 2020, and May 1, 2025, and alleges that the company misled the market about its business model and regulatory exposure.

Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now.

Class Period: Sept. 9, 2020 – May 1, 2025
Lead Plaintiff Deadline: Oct. 10, 2025
Visit: www.hbsslaw.com/investor-fraud/slqt
Contact the Firm Now: SLQT@hbsslaw.com
844-916-0895

Allegations of Kickbacks and Misrepresentation

At the heart of the complaint are claims that SelectQuote misrepresented its Medicare Advantage sales practices. While the company publicly promoted its services as offering “unbiased advice” and “neutral plan comparisons,” the lawsuit asserts that SelectQuote:

  • Steered customers toward plans from insurers offering the highest commissions.
  • Accepted illegal kickbacks in exchange for preferential treatment.
  • Violated federal statutes, including the False Claims Act

The DOJ’s complaint alleges that from 2016 through at least 2021, SelectQuote received tens of millions of dollars in improper payments and discriminated against less profitable customers by directing them away from lower-margin plans.

Market Fallout and Investor Impact

The DOJ’s involvement sent shockwaves through the market, with SelectQuote’s stock plunging nearly 20% in a single day. Over the past six months, shares have declined more than 40%, reflecting investor concern over the company’s legal exposure and potential reputational damage.

The class-action lawsuit argues that SelectQuote’s public statements failed to disclose material risks tied to its sales practices, leading investors to overvalue the company’s growth prospects and revenue integrity.

Hagens Berman Investigates Alleged Revenue Manipulation

Shareholder rights firm Hagens Berman is investigating whether SelectQuote’s revenue was artificially inflated through deceptive conduct. Reed Kathrein, a partner at the firm, commented: “The DOJ’s intervention transforms this from a routine business dispute into a serious federal matter. We’re examining whether SelectQuote’s so-called ‘unbiased’ model was merely a façade for a kickback-driven sales engine.”

If you invested in SelectQuote and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to frequently asked questions about the SelectQuote case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding SelectQuote should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email SLQT@hbsslaw.com.

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contacts

Reed Kathrein, 844-916-0895

Hagens Berman

NYSE:SLQT

Release Versions

Contacts

Reed Kathrein, 844-916-0895

More News From Hagens Berman

ALT5 Investor Alert: Hagens Berman Investigates ALT5 Sigma (ALTS) Over Auditor Resignation and Potentially False Financials

SAN FRANCISCO--(BUSINESS WIRE)--National shareholder rights law firm Hagens Berman has opened an investigation into ALT5 Sigma Corporation (NASDAQ: ALTS) following a cascade of regulatory and management failures that led to the company’s stock cratering nearly 80%. The investigation focuses on whether ALT5 misled investors about the stability and reliability of its financial reporting and internal controls—specifically in the context of its $1.5 billion registered offering in mid-August. Just t...

Hagens Berman: Oregon Lawsuit Alleging Nitrate-Polluted Groundwater Filed Against Power Company and Dairy Manufacturer

PENDLETON, Ore.--(BUSINESS WIRE)--Oregon residents represented by attorneys at Hagens Berman allege Tillamook and Portland General Electric have contaminated local groundwater....

KLAR INVESTOR ALERT: Hagens Berman Scrutinizing Klarna (KLAR) Amid 102% Spike in Credit Loss Provision Risk Tied to Fair Financing Growth

SAN FRANCISCO--(BUSINESS WIRE)--National shareholder rights law firm Hagens Berman has launched an investigation into potential securities law violations by Klarna Group plc (NYSE: KLAR) following the company’s recent Q3 2025 financial results. The disappointing results revealed a staggering increase in the provision for credit losses. The company has seen a decline of approximately 23.6% from its initial public offering (IPO) price of $40.00 per share on September 9, 2025. The investigation fo...
Back to Newsroom